Free Trial

Upexi (NASDAQ:UPXI) Stock Rating Lowered by Wall Street Zen

Upexi logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen downgraded Upexi from a "sell" to a "strong sell" in a report issued on Saturday, signaling heightened analyst concern about the stock.
  • In the most recent quarter Upexi reported a large EPS miss of ($2.94) vs. ($0.08) expected, with revenue of $10.96M but a severely negative net margin (~496.9%) and ROE of -41.47%.
  • Analyst views are mixed—MarketBeat shows a consensus rating of "Moderate Buy" and a $8.33 target while firms like Cantor Fitzgerald rate it "strong-buy"—even as the shares trade around $1.30 (market cap ~$90M) and the company carries a high debt/equity ratio (2.96).
  • Interested in Upexi? Here are five stocks we like better.

Upexi (NASDAQ:UPXI - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "sell" rating to a "strong sell" rating in a report issued on Saturday.

UPXI has been the subject of several other reports. iA Financial set a $8.00 target price on shares of Upexi in a research note on Tuesday, January 13th. Cantor Fitzgerald raised shares of Upexi to a "strong-buy" rating in a research note on Thursday, April 9th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $8.33.

Read Our Latest Report on UPXI

Upexi Stock Down 1.5%

UPXI stock opened at $1.30 on Friday. The stock has a market capitalization of $90.14 million, a P/E ratio of -0.40 and a beta of -0.32. The company has a debt-to-equity ratio of 2.96, a quick ratio of 2.19 and a current ratio of 2.20. Upexi has a one year low of $0.54 and a one year high of $16.00. The company has a 50 day moving average price of $1.06 and a two-hundred day moving average price of $2.10.

Upexi (NASDAQ:UPXI - Get Free Report) last released its earnings results on Tuesday, February 10th. The company reported ($2.94) EPS for the quarter, missing the consensus estimate of ($0.08) by ($2.86). The firm had revenue of $10.96 million during the quarter, compared to analysts' expectations of $9.42 million. Upexi had a negative return on equity of 41.47% and a negative net margin of 496.86%.

Institutional Trading of Upexi

A number of institutional investors and hedge funds have recently made changes to their positions in UPXI. Geode Capital Management LLC acquired a new stake in shares of Upexi during the 2nd quarter worth $1,002,000. SG Americas Securities LLC acquired a new stake in shares of Upexi during the 3rd quarter worth $177,000. Arkadios Wealth Advisors acquired a new stake in shares of Upexi during the 3rd quarter worth $58,000. Belpointe Asset Management LLC acquired a new stake in shares of Upexi during the 3rd quarter worth $58,000. Finally, Phoenix Financial Ltd. acquired a new stake in shares of Upexi during the 3rd quarter worth $404,000. 5.68% of the stock is currently owned by institutional investors and hedge funds.

Upexi Company Profile

(Get Free Report)

Upexi NASDAQ: UPXI is a full-service digital consultancy that partners with brands to design, develop, and deploy digital products and marketing strategies. The company's expertise spans user experience and interface design, custom software engineering, and data-driven marketing services. By integrating research, creative design, and technical execution, Upexi helps clients accelerate product development cycles and optimize their digital presence.

The firm serves a diverse, global clientele across sectors such as e-commerce, software-as-a-service (SaaS), healthcare, and finance.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Upexi Right Now?

Before you consider Upexi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Upexi wasn't on the list.

While Upexi currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines